UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                -----------------

                                   FORM 10-QSB

                                -----------------

          [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                         SECURITIES EXCHANGE ACT OF 1934

                     For the period ended September 30, 2003

                                       OR

          [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (D) OF THE
                         SECURITIES EXCHANGE ACT OF 1934


                                -----------------

                        Commission File Number: 000-30697


                            PERFECT HEALTH CARE CORP.
           ----------------------------------------------------------
           (Exact name of small business as specified in its charter)



                 Nevada                                  48-1302159
   ----------------------------------               -------------------
    (State or other jurisdiction of                    (IRS Employer
     incorporation or organization)                 Identification No.)



                   4017 Colby Ave., Everett, Washington 98201
            --------------------------------------------------------
                    (Address of principal executive offices)


                                 (425) 258-4222
                          ---------------------------
                          (Issuer's telephone number)


                                      -i-
<PAGE>

Check whether the issuer (1) filed all reports required to be filed by Section
13 or 15(d) of the Securities Exchange Act during the past 12 months (or for
such shorter period that the registrant was required to file such reports), and
(2) has been subject to such filing requirements for the past 90 days.

         Yes [ X ]          No [   ]

The Company had 22,600,000 shares of common stock outstanding at May 1, 2003.

Transitional Small Business Disclosure Format (check one):

         Yes [   ]          No [ X ]


                                      -ii-
<PAGE>
                         PART I. FINANCIAL INFORMATION

Item 1.  Financial Statements (Unaudited)

                             RANDY SIMPSON CPA, P.C.
                            11775 SOUTH NICKLAUS ROAD
                                SANDY, UTAH 84092
                              PHONE (801) 572-3009

Board of Directors and Stockholders
Perfect Health Care Corp.

                     INDEPENDENT ACCOUNTANT'S REVIEW REPORT

I have reviewed the accompanying balance sheet of Perfect Health Care Corp. (A
Nevada Corporation) as of September 30, 2003, and the related statements of
operations and cash flows for the three months then ended, in accordance with
Statements on Standards of Accounting and Review Services issued by the American
Institute of Certified Public Accountants. All information included in these
financial statements is the representation of the management of Perfect Health
Care Corp.

A review consists principally of inquiries of company personnel and analytical
procedures applied to financial data. It is substantially less in scope than an
audit in accordance with generally accepted auditing standards, the objective of
which is the expression of an opinion regarding the financial statements taken
as a whole. Accordingly, I do not express such an opinion.

Based on my review, I am not aware of any material modifications that should be
made to the accompanying financial statements in order for them to be in
conformity with generally accepted accounting principles.

I have audited, in accordance with generally accepted auditing standards, the
balance sheet of Perfect Health Care Corp. as of June 30, 2003 and the related
statements of operations, stockholders' equity, and cash flows for the year then
ended (not presented herein); and in my report dated September 26, 2003, I
expressed an unqualified opinion on those financial statements. In my opinion,
the information set forth in the accompanying balance sheet as of June 30, 2003
is fairly stated in all material respects in relation to the balance sheet from
which it has been derived.


Randy Simpson, CPA, P.C.
A Professional Corporation

November 19, 2003
Sandy, Utah

                                      -1-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                         (A development stage company)
                                  Balance Sheet
                         September 30 and June 30, 2003

<TABLE>
<CAPTION>
                                                              SEPTEMBER 30        JUNE 30
                                                                  2003              2003
                                                             -------------    --------------
        ASSETS                                                (Unaudited)

Current assets

<S>                                                          <C>              <C>
      Cash and cash equivalents                              $    112,358     $     246,516
      Accounts receivable                                          46,815            56,758
      Prepaid expenses                                             68,494            32,776
                                                             -------------    --------------
                                   TOTAL CURRENT ASSETS           227,667           336,050

PROPERTY AND EQUIPMENT

      Office furniture and equipment                               13,371            11,309
      Vehicles                                                      6,064             6,064
      Leasehold improvements                                        1,588             1,588
      Assets under capital leases                                 188,262           188,262
      Less - accumulated depreciation
        and amortization                                          (22,770)          (11,176)
                                                             -------------    --------------
                             NET PROPERTY AND EQUIPMENT           186,516           196,047
                                                             -------------    --------------

                                                             $    414,183     $     532,097
                                                             =============    ==============

        LIABILITIES AND STOCKHOLDERS' EQUITY

Current Liabilities

      Accounts payable and accrued liabilities               $     17,091     $      18,407
      Deferred revenue                                             60,660            74,975
      Advances by stockholder and director                         28,951            20,000
      Current portion of capital lease obligations                 51,805            50,816
                                                             -------------    --------------
                              TOTAL CURRENT LIABILITIES           158,507           164,198

LONG TERM LIABILITIES

      Capital lease obligations                                   163,819           176,158
      Less - current portion of capital lease obligations         (51,805)          (50,816)
                                                             -------------    --------------
                            TOTAL LONG TERM LIABILITIES           112,014           125,342

STOCKHOLDERS' EQUITY

      Series A convertible preferred stock                          1,600             1,600
      Common stock                                                 23,395            23,066
      Paid in capital                                             597,305           531,834
      Less stock subscriptions receivable                          (7,500)          (72,500)

                                    ACCUMULATED DEFICIT          (471,137)         (241,443)
                                                             -------------    --------------
                             TOTAL STOCKHOLDERS' EQUITY           143,663           242,557
                                                             -------------    --------------

                                                             $    414,183     $     532,097
</TABLE>


                 See accompanying notes to financial statements.

                                      -2-

<PAGE>
                            PERFECT HEALTH CARE CORP.
                         (A development stage company)
                             Statement of Operations
                 Three Months Ended September 30, 2003 and 2002


<TABLE>
<CAPTION>
                                                      September 30,      September 30,
                                                           2003               2002
                                                     ---------------     ---------------
                                                       (Unaudited)         (Unaudited)


<S>                                                  <C>                 <C>
INCOME FROM CARD SALES                               $       33,097      $

COST OF CARD SALES                                           11,267
                                                     ---------------     ---------------

GROSS PROFIT                                                 21,830                   -

EXPENSES

      Selling,general and administrative expense            235,807               1,812
      Interest expense - net                                  4,124
      Depreciation                                           11,594
                                                     ---------------     ---------------

                                     TOTAL EXPENSES         251,524               1,812
                                                     ---------------     ---------------


                                           NET LOSS  $     (229,695)     $       (1,812)
                                                     ===============     ===============


Net Loss Per Common Share                            $        (0.01)     $        (0.00)
                                                     ===============     ===============

Weighted Average Common Shares Outstanding               23,285,330          21,000,000
                                                     ===============     ===============
</TABLE>




                 See accompanying notes to financial statements.




                                      -3-
<PAGE>

                            PERFECT HEALTH CARE CORP.
                         (A development stage company)
                             Statement of Cash Flows
                 Three Months Ended September 30, 2003 and 2002

                                                  2003             2002
                                             -------------    -------------
                                              (Unaudited)      (Unaudited)

Cash used by operating activities            $   (119,756)    $          -
INVESTING ACTIVITIES

     Purchase of property and equipment            (2,062)

FINANCING ACTIVITIES

     Payments on capital leases                   (12,339)
                                             -------------    -------------

NET DECREASE IN CASH                             (134,158)               -

CASH AT THE BEGINNING OF THE PERIOD               246,516                -
                                             -------------    -------------

CASH AT THE END OF THE PERIOD                $    112,358     $          -
                                             =============    =============


CASH PAYMENTS FOR INCOME TAXES               $          -     $          -
                                             =============    =============

CASH PAYMENTS FOR INTEREST                   $      4,124     $          -
                                             =============    =============




                 See accompanying notes to financial statements.




                                      -4-
<PAGE>

1.   ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES ORGANIZATION
     AND NATURE OF OPERATIONS

     Perfect Health Care Corp. ("the Company") was incorporated in the State of
     Utah on August 17, 1987 as Love Calendar, Inc., for the purpose of
     developing and marketing specialty advertising and promotional products.
     The Company raised a modest amount of capital in a Rule 504 limited
     offering, but was generally unsuccessful in developing the concept into a
     viable enterprise. Ultimately the Company abandoned its business plan After
     exhausting its funds and after failing to raise additional capital.
     Following several years of seeking out and examining a number of business
     opportunities, the Company adopted the current business plan.

     In April, 2003 the Board of Directors adopted, and the shareholders
     approved, a plan of reorganization whose sole purpose and effect was to
     move the company's domicile from Utah to Nevada. Shortly thereafter, the
     Company appointed new officers and adopted its current business plan.

     The Company is engaged in the business that addresses the growing need in
     the U.S. for access to affordable health care. The major product is the
     National Health Care Card (Card) which supplements insurance and other
     options available to consumers to reduce their out-of-pocket costs for
     health care services and prescriptions. The Card is not an insurance
     product. Rather, the Card provides the consumer with access to networks of
     providers who are members of Preferred Provider Organizations or other
     provider organizations. Such providers have agreed to honor the Card and
     accept reduce fees from patients who pay cash for their services and
     prescription drugs.

     Customers enter into a contract with the Company to purchase the Card on
     either an annual or monthly basis. Annual contracts are paid for in
     advance. The Company does not pay any portion of the fee for services or
     prescriptions purchased with the Card by customers. Rather the Company
     provides a "hotline" to customers through which enrolled providers in the
     customer's general area are located and other related customer problems are
     addressed.

     USE OF ESTIMATES

     The preparation of financial statements in conformity with generally
     accepted accounting principles requires management to make estimates and
     assumptions that affect the reported amounts of assets and liabilities and
     disclosure of contingent assets and liabilities at the date of the
     financial statements and the reported amounts of revenues and expenses
     during the reporting period. Actual results could differ from those
     estimates.



                                      -5-
<PAGE>

     The Company sells the Card either through annual contracts with customer
     payment due at the time the contract is executed or on a month-to-month
     basis with payment due each month. Revenue from the sale of annual
     contracts is recognized in the month it is earned. Revenue related to
     month-to-month agreements is recognized as payments are received from the
     customers.

     EXPENSE RECOGNITION

     In accordance with the above revenue recognition policy, the Company defers
     the cost of retentions (amounts paid to sellers of the product) and
     fulfillment cost (costs of literature and card preparation and mailing)
     related to annual contracts and includes these in prepaid expenses. Such
     assets are charged to expense in the same manner in which the revenue is
     recognized.

     CASH AND CASH EQUIVALENTS

     Cash and cash equivalents consist primarily of cash on deposit or cash
     investments purchased with original maturities of three months or less.

     PREPAID EXPENSES

     Prepaid expenses consist mainly of retention and fulfillment costs related
     to annual contracts. See "Expense Recognition", above.

     PROPERTY AND EQUIPMENT

     Depreciation and amortization are charged to operations, using the
     straight-line method, over the estimated useful lives of the related assets
     as follows:

         Office furniture & equipment                3 - 5 years
         Vehicles                                    5 years
         Leasehold improvements                      3 years
         Assets under capital leases                 3 - 5 years

     Maintenance, repairs and minor renewals are charged to operations as
     incurred. Additions and betterments are capitalized. When assets are
     disposed of, the related cost and accumulated depreciation are removed from
     the accounts and any gain or loss is included in operations.

     DEFERRED REVENUE

     Deferred revenue consists of amounts received from annual contracts for
     which the Company's period of performance has not passed. See "Revenue
     Recognition", above.



                                      -6-
<PAGE>

     Stock subscriptions receivable consists on amounts owed at June 30, 2003 by
     subscribers to the Company's private placement. Such amounts were collected
     subsequent to year end.

     INCOME TAXES

     Provisions for income taxes are based on taxes payable or refundable for
     the current year and deferred taxes on temporary differences between the
     amount of taxable income and pretax financial income and between the tax
     basis of assets and liabilities and their reported amounts in the financial
     statements. Deferred tax assets and liabilities are included in the
     financial statements at currently enacted income tax rates applicable to
     the period in which the deferred tax assets and liabilities are expected to
     be realized or settled as prescribed in FASB Statement No. 109, Accounting
     for Income Taxes. As changes in tax laws or rates are enacted, deferred tax
     assets and liabilities are to be adjusted through the provision for income
     taxes. At June 30, 2003 the Company had not provided for any deferred tax
     liabilities due to lack of profitable operations and no deferred tax assets
     due to the availability of net operating loss carry forwards. At June 30,
     2003 the Company had approximately $165,000 of net operating loss carry
     forwards which expire in 2018.

     EARNINGS PER SHARE

     Earnings per share is calculated based on the weighted average number of
     common shares outstanding. Preferred shares and warrants are not included
     in the calculation of earnings per share because the effect would be
     anti-dilutive.

     CONCENTRATION OF CREDIT RISK

     The Company maintains its cash in bank deposit accounts which, at times,
     may exceed federally insured limits. The Company has not experienced any
     losses in such accounts and believes it is not exposed to any significant
     risk.

     FAIR VALUE OF FINANCIAL INSTRUMENTS

     The recorded amounts of cash, cash equivalents, accounts receivable,
     prepaid expenses, accounts payable, accrued liabilities and deferred
     revenue approximate fair value because of the short-term maturity of these
     items.



                                      -7-
<PAGE>

     RECENT ACCOUNTING PRONOUNCEMENTS

     In July 2001, the Financial Accounting Standards Board issued Statement of
     Financial Accounting Standards No. 141, Business Combinations (SFAS 141),
     and Statement of Financial Accounting Standards No. 142, Goodwill and Other
     Intangible Assets (SFAS 142). They also issued Statement of Financial
     Accounting Standards

     No. 143, Accounting for Obligations Associated with the Retirement of
     Long-Lived Assets (SFAS 143), and Statement of Financial Accounting
     Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived
     Assets (SFAS 144), in August and October 2001, respectively. In April and
     June 2002, the Financial Accounting Standards Board issued Standard No.
     145, Reporting Gains and Losses from Extinguishment of Debt (SFAS 145) and
     Standard No. 146, Accounting for Costs Associated with Exit or Disposal
     Activities (SFAS 146). In December 2002, the Financial Accounting Standards
     Board issued Statement of Financial Accounting Standard No. 148, Accounting
     for Stock-Based Compensation-Transition and Disclosure (SFAS 148). In April
     2003 the Financial Accounting Standards Board issued Statement of Financial
     Accounting Standard No. 149, Amendment of Statement 133 on Derivative
     Instruments and Hedging Activities (SFAS 149). In May 2003 the Financial
     Accounting Standards Board issued Statement of Financial Accounting
     Standard No. 150, Accounting for Certain Financial Instruments with
     Characteristics of both Liabilities and Equity (SFAS 150).

     SFAS 141 requires that all business combinations initiated after June 30,
     2001 be accounted for under the purchase method. SFAS 141 supersedes APB
     Opinion No. 16, Business Combinations, and Statement of Financial
     Accounting Standards No. 38, Accounting for Pre-acquisition Contingencies
     of Purchased Enterprises, and is effective for all business combinations
     initiated after June 30, 2001. The Company's issuance of common stock in
     connection with the acquisition of all the issued and outstanding shares of
     Love Calendar, Inc. was accounted for as a purchase in accordance with this
     Statement.

     SFAS 142 addresses the financial accounting and reporting for acquired
     goodwill and other intangible assets. Under these rules, the Company is no
     longer required or allowed to amortize goodwill and other intangible assets
     with indefinite lives, but is subject to periodic testing for impairment.
     SFAS 142 supersedes APB Opinion No. 17, Intangible Assets. The Company
     adopted SFAS 142, which resulted in the write-off of goodwill recorded in
     connection with the acquisition of Love Calendar, Inc. SFAS 143 establishes
     accounting standards for the recognition and measurement of an asset
     retirement obligation and its associated asset retirement cost. It also
     provides accounting guidance for legal obligations associated with the
     retirement of tangible long-lived assets. SFAS 143 is effective in fiscal
     years beginning after June 15, 2002, with early adoption permitted. The
     provisions of SFAS 143 did not have a material impact on the Company's
     results of operations and financial position.



                                      -8-
<PAGE>

     SFAS 144 establishes a single accounting model for the impairment or
     disposal of long-lived assets, including discontinued operations. SFAS 144
     superseded Statement of Financial Accounting Standards No. 121, Accounting
     for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be
     Disposed Of (SFAS 121), and APB Opinion No. 30, Reporting the Results of
     Operations - Reporting the Effects of Disposal of a Segment of a Business,
     and Extraordinary, Unusual and Infrequently Occurring Events and
     Transactions. The provisions of SFAS 144 are effective in fiscal years
     beginning after December 15, 2001, with early adoption permitted, and in
     general are to be applied prospectively. The adoption of SFAS 144 did not
     have a material impact on the Company's results of operations and financial
     position.

     SFAS 145 rescinds SFAS No. 4, Reporting Gains and Losses from
     Extinguishment of Debt, SFAS No. 44, Accounting for Intangible Assets of
     Motor Carriers and SFAS No. 64, Extinguishments of Debt Made to Satisfy
     Sinking-Fund Requirements. SFAS 145 amends SFAS No. 13, Accounting for
     Leases, to eliminate an inconsistency between the required accounting for
     sale-leaseback transactions and the required accounting for certain lease
     modifications that have economic effects that are similar to sale-leaseback
     transactions. SFAS 145 is effective in fiscal years beginning after May 15,
     2002, with early adoption permitted. The provisions of SFAS 145 did not
     have a material impact on the Company's consolidated results of operations
     and financial position.

     SFAS 146, Accounting for Costs Associated with Exit or Disposal Activities
     addresses the accounting and reporting for costs associated with exit or
     disposal activities. SFAS 146 requires that a liability for a cost
     associated with an exit or disposal activity be recognized when the
     liability is incurred. Previously, under Emerging Issues Task Force (EITF)
     Issue No. 94-3, Liability Recognition for Certain Employee Termination
     Benefits and Other Costs to Exit an Activity (including Certain Costs
     Incurred in a Restructuring), a liability for an exit cost was recognized
     at the date of an entity's commitment to an exit plan. Under SFAS 146, an
     entity's commitment to a plan, by itself, does not create a present
     obligation to others that meets the definition of a liability. Therefore,
     SFAS 146 eliminates the definition of exit costs in Issue 94-3. SFAS 146
     also establishes that fair value is the objective for initial measurement
     of the liability. The provisions of SFAS 146 are effective for exit or
     disposal activities that are initiated after December 31, 2002, with early
     adoption permitted. The Company expects that the provisions of SFAS 146
     will not have a material impact on its results of operations and financial
     position upon adoption. The Company plans to adopt SFAS 146 effective July
     1, 2003.



                                      -9-
<PAGE>

     SFAS 148, Accounting for Stock-Based Compensation--Transition and
     Disclosure, amends SFAS No. 123, Accounting for Stock-Based Compensation,
     to provide alternative methods of transition for a voluntary change to the
     fair value base method of accounting for stock based employee compensation.
     In addition, SFAS 148 amends the disclosure requirements of SFAS No. 123 to
     require prominent disclosures in both annual and interim financial
     statements about the method for accounting for stock-based employee
     compensation and the effect of the method used in reported financial
     results. SFAS 148, paragraphs 2(a)-2(e), are effective for financial
     statements for fiscal years ending after December 15, 2002. Earlier
     application is permitted. SFAS 148 paragraph 2(f) and the amendment to APB
     Opinion No. 28, Interim Financial Reporting, shall be effective for
     financial reports containing condensed statements for interim periods
     beginning after December 15, 2002. Earlier adoption is permitted. The
     Company adopted the disclosure provisions of SFAS 148 effective June 30,
     2003. As permitted under SFAS 148 the Company continues to apply the
     recognition provisions of APB Opinion No. 25. Accounting for stock issued
     to employees, in determining its stock compensation expense.

     SFAS 149, Amendment of Statement 133 on Derivative Instruments and Hedging
     Activities, amends and clarifies financial accounting and reporting for
     derivative instruments, including certain derivative instruments imbedded
     in contracts and for hedging activities under FASB Statement No. 133,
     Accounting for Derivative Instruments and Hedging Activities. SFAS 149 is
     effective for contracts entered into after June 30, 2003. The Company
     expects that the provisions of SFAS 149 will not have a material impact on
     its results of operations and financial position upon adoption.

     SFAS 150, Accounting for Certain Financial Instruments with Characteristics
     of both Liabilities and Equity, establishes standards for how an issuer
     classifies and measures certain financial instruments with characteristics
     of both liability and equity. It requires that an issuer classify a
     financial instrument that is within its scope as a liability (or an asset
     in some circumstances). The Statement is effective for financial
     instruments entered into or modified after May 31, 2003, and is otherwise
     effective at the beginning of the first interim period beginning after June
     15, 2003. The Company expects that the provisions of SFAS 150 will not have
     a material impact on its results of operations and financial position upon
     adoption.

     In August 2002, Congress adopted the Sarbanes-Oxley Act of 2002, imposing
     new, more stringent accounting and reporting requirements on all public
     companies. The Company has complied with all applicable requirements of
     Sarbanes-Oxley, and these requirements did not have a material impact on
     the Company's financial position or results of operations.



                                      -10-
<PAGE>

2.   REORGANIZATION

     In April 2003 the Company issued 21,000,000 common shares to acquire all
     the 2,100,000 issued and outstanding common shares of Love Calendar, Inc.
     Love Calendar, Inc. had previously been a "public reporting shell"
     corporation with no significant operations of its own either before or
     after the acquisition.

     The transaction has been accounted for as a purchase in accordance with
     SFAS 141. The purchase price, net of a $10,000 liability assumed by the
     Company, was $15,000 and was determined by estimating the cost of
     registering the Company's shares under Section 12(g) of the Act. This
     resulted in goodwill of $25,000.

     Based on the requirements of SFAS 142, this goodwill was subsequently
     tested for impairment. Due to the lack of historic operating profits and
     the non-assurance of future profitable operations, the entire amount of
     goodwill was written off at June 30, 2003 and included in general and
     administrative expense in the accompanying financial statements. None of
     this amount is expected to be deductible for income tax purposes.

     Following is a condensed balance sheet for Love Calendar, Inc. at the
     acquisition date:

             Goodwill                          $25,000
                                               -------
             Total Assets                      $25,000
                                               =======

             Advance by stockholder            $10,000
             Net equity                         15,000
                                              --------
             Total liabilities and equity      $25,000
                                               =======


3.   CAPITAL STOCK

     The Company's capital stock consists of the following:

          Series "A" convertible preferred stock - par value $.001, authorized
          25,000,000 shares; 1,600,000 shares issued and outstanding in 2003,
          none in 2002. Each share of Series "A" convertible preferred stock is
          convertible into 10 shares of the Company's common stock at the option
          of the holder.



                                      -11-
<PAGE>

          Common stock - par value $.001, authorized 200,000,000 shares;
          23,066,000 shares issued and outstanding in 2003, 21,000,000 in 2002.

     In April 2003 the Company approved a 10 for 1 split of its common shares
     with no change in the par value. This split has been retroactively
     reflected in the accompanying financial statements.

     PRIVATE PLACEMENT - In June 2003 the Company completed a private placement
     of its common stock in which it realized $516,500 through the sale of
     2,066,000 shares of common stock at $.25 per share. Subscribers also
     received a warrant to purchase one share of common stock with each four
     shares purchased in the private placement. The exercise price of each
     warrant is $.50 per share and all warrants expire, if not exercised, on
     August 29, 2004. At September 30, 2003, $7,500 related to the private
     placement had not been collected and is shown as stock subscriptions
     receivable in the accompanying financial statements.

     SERIES "A" CONVERTIBLE PREFERRED STOCK - On April 9, 2003 the Company
     issued 1,600,000 shares of its Series "A" convertible preferred stock to
     its president in connection with consulting services he provided during the
     Company's formation and start-up. The preferred stock was valued at
     approximately $.016 per share.

4.   CAPITAL LEASES

     In March 2003 the Company assumed certain capital leases originally entered
     into by another company which is currently in bankruptcy. The leases are
     for computer equipment, copiers and a phone system and are guaranteed by an
     otherwise non-affiliated company controlled by the president.

     Capital lease amounts included in Property and equipment at June 30, 2003
     are as follows:

         Assets under capital leases       $182,262
         Accumulated amortization           (10,463)
                                            --------
         Total                             $171,799
                                            =======




                                      -12-
<PAGE>

     Minimum capital lease obligations, net of interest and executory costs at
     June 30, 2003 are as follows:

          2004          $ 50,816
          2005            47,680
          2006            40,049
          2007            33,936
          2008             3,677
                        --------
          Total         $176,158
                        ========

5.   RELATED PARTY TRANSACTIONS

     OFFICE RENTAL - The Company rents office space from the president on a
     month-to-month basis for $2,375 per month.

     ADVANCE BY STOCKHOLDER - The Company assumed a $10,000 liability to a
     shareholder as a result of the acquisition of Love Calendar, Inc.
     Management intends to extinguish this liability through the subsequent
     issuance of stock in the Company.

     ADVANCE BY DIRECTOR - a director advanced $10,000 to the Company to assist
     with start-up. This advance is non-interest bearing and due on demand.

6.   STOCK PLAN

     Pursuant to the 2003 Stock Option and Restricted Stock Benefit Plan, the
     Company issued 329,000 shares of the Company's common stock to officers and
     key employees in July, 2003.


ITEM 2 - Management's Discussion and Analysis or Plan of Operation

NOTE: The following discussion should be read in conjunction with our unaudited
interim financial statement for the three months ended September 30, 2003 and
our audited financial statement for the fiscal year ended June 30, 2003.



                                      -13-
<PAGE>

Three Months Ended September 30, 2003 versus 2002.

Revenues for the quarter ended September 30, 2003 were $33,097, compared to $0
for the same period in 2002. Operating expenses for the quarter were $251,524
compared with $1,812 for prior year. The increase is attributable to our entry
into the membership medical savings card business in April of 2003, whereas the
Company had only minimal activity in the prior year. Total operating loss for
the quarter was $229,695, or about $.01 per share, versus $1,812 for 2002.

Plan of Operation

Although we are achieving some sales on a regular basis, our current level of
revenues is not sufficient to cover our operating expenses. We will have to
raise additional capital within the next three months in order to continue our
marketing and other business development activities. If we are unable to raise
additional capital we may be unable to continue in business.


                          PART II - OTHER INFORMATION


ITEM 1 - Legal Proceedings

Insofar as we are aware, there are no legal proceedings, either current,
pending, or threatened, involving us or our properties.


ITEM 2 - Changes in Securities and Use of Proceeds

During the period we issued a total of 329,000 shares of restricted common stock
to two executive officers and an employee under our 2003 Stock Benefit Plan.

ITEM 3 - Defaults Upon Senior Securities

None.

ITEM 4 - Submission of Matters to a Vote of Security Holders

None.

ITEM 5 - Other Information




                                      -14-
<PAGE>

ITEM 6 - Exhibits and Reports On Form 8-K

a.  Reports on Form 8-K:

     None

b.   Exhibits

     Exhibit No.      Description
     -----------      -----------




                                   SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                                PERFECT HEALTH CARE CORP.


November 19, 2003                               /s/ Antoine Jarjour
-------------------                             ----------------------------
  Date                                          President, Acting Chief
                                                Financial Officer




                                      -15-

<PAGE>

                                 CERTIFICATION

Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002:

I, Antoine Jarjour, certify that:

1. I have reviewed this quarterly report on Form 10-QSB of Perfect Health Care
Corp.;

2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the periods presented in this quarterly report;

4. The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as defined in
Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

     a) designed such disclosure controls and procedures to ensure that material
     information relating to the registrant, including its consolidated
     subsidiaries, is made known to us by others within those entities,
     particularly during the period in which this quarterly report is being
     prepared;

     b) evaluated the effectiveness of the registrant's disclosure controls and
     procedures as of a date within 90 days prior to the filing date of this
     quarterly report (the "Evaluation Date"); and

     c) presented in this quarterly report our conclusions about the
     effectiveness of the disclosure controls and procedures based on our
     evaluation as of the Evaluation Date;

5. The registrant's other certifying officers and I have disclosed, based on our
most recent evaluation, to the registrant's auditors and the audit committee of
registrant's board of directors (or persons performing the equivalent function):

     a) all significant deficiencies in the design or operation of internal
     controls which could adversely affect the registrant's ability to record,
     process, summarize and report financial data and have identified for the
     registrant's auditors any material weaknesses in internal controls; and

     b) any fraud, whether or not material, that involves management or other
     employees who have a significant role in the registrant's internal
     controls; and

6. The registrant's other certifying officers and I have indicated in this
quarterly report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal controls
subsequent to the date of our most recent evaluation, including any corrective
actions with regard to significant deficiencies and material weaknesses.

Date: November 19, 2003

/s/ Antoine Jarjour
------------------------------
President, CEO, and
Acting Chief Financial Officer